(Q67780763)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

The antiglucocorticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

The antiglucocoticoid RU486 downregulates the expression of interleukin-2 receptors in normal human lymphocytes (English)

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

15 November 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

adrenal cortex hormone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

clinical research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

developed country

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

hormone antagonist

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

Mediterranean Countries

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

Southern Europe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

dexamethasone acetate

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

15 November 2022

author name string

N. Antonakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

E. Markogiannakis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

M. Theodoropoulou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

V. Georgoulias

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

C. Stournaras

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

A. Gravanis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1751392

15 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1751392

15 November 2022

publication date

1 December 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:0960076091903515?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

https://api.elsevier.com/content/article/PII:0960076091903515?httpAccept=text/plain

15 November 2022

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

The Journal of Steroid Biochemistry and Molecular Biology

15 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

929-935

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women

17 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.

15 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone)

15 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

15 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

The Effects of RU 486 on Immune Function and Steroid-Induced Immunosuppressionin Vitro*

15 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Pharmacodynamics of the antiprogesterone RU486 in women after oral administration

15 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor

15 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's

15 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

The two-chain structure of high-affinity IL-2 receptors

15 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression

15 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Effect of wheat germ agglutinin on the interleukin pathway of human T lymphocyte activation

15 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

15 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

15 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

15 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

Differential expression of the beta-tubulin multigene family during rat brain development

15 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0960-0760(91)90351-5

15 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1751392%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference